Abstract
Abstract
The pterygopalatine fossa (PPF) is a small, clinically inaccessible, fat-filled space located in the deep face that serves as a major neurovascular crossroad between the oral cavity, nasal cavity, nasopharynx, orbit, masticator space, and the middle cranial fossa. Due to its inherent complex location and connections, it can potentially act as a natural conduit for the spread of inflammatory and neoplastic diseases across the various deep spaces in the head and neck. This review aims to acquaint the reader with the imaging anatomy of the PPF, its important communications, and to identify some major pathological conditions that can involve the PPF, especially in conditions where its involvement can have serious diagnostic and therapeutic implications, such as in perineural tumour spread.
Teaching points
• The PPF is a small neurovascular junction in the deep face with important to-and-fro connections.
• Awareness of anatomy of the PPF and its communications helps to simplify imaging of its pathology.
• Perineural tumour spread is clinically the most important pathology in this region.
Keywords: Pterygopalatine fossa, CT, MRI, Perineural tumour spread
Introduction
The pterygopalatine fossa (PPF) is an obscure but important space in the deep face that needs to be evaluated very carefully in the realm of head and neck imaging, since a myriad of infective, inflammatory, and neoplastic conditions can affect it. These conditions may not only be difficult to detect clinically, but also difficult to treat, if not diagnosed accurately. The multiple communications of the PPF with the deep neck spaces serve as ready pathways for loco-regional spread of disease. Therefore, familiarity with its complex anatomy and thorough understanding of the imaging features of its common pathologies are mandatory to improve diagnostic accuracy as well as patient management [1–7].
Imaging anatomy, contents, and major communications of the PPF
The PPF is an inverted pyramid-shaped space bounded by the junction of the maxilla, palatine, and sphenoid bones. The PPF contains fat, the pterygopalatine ganglion (PPG), the maxillary division (V2) of the trigeminal nerve and its branches [zygomatic nerve, posterior superior alveolar nerve(s), and the infraorbital nerve (ION)], the Vidian (pterygoid) nerve, the distal branches of the maxillary artery, and a few emissary veins [1–7] (Fig. 1).
High-resolution computed tomography (HRCT) is the modality of choice for evaluating the various bony communications of the PPF. Typically, very thin axial sections are obtained on a multidetector CT scanner, parallel to the lower borders of the upper teeth, starting from the hard-palate to the mid-hypophyseal fossa. Coronal reformats are obtained parallel to the posterior wall of the maxillary sinus back to the level of the posterior clinoids [4].
By using the aforementioned planes of acquisition, the most caudal structure of the PPF (apex of pyramid) as identified on axial HRCT sections, is the greater palatine canal, which descends within the posteroinferior aspect of the medial wall of the maxillary bone to open as the greater palatine foramen in the posterolateral aspect of the hard palate (Fig. 2a and b). The lesser palatine canal is seen posterior to the greater palatine canal, traversing the pyramidal process of the palatine bone and opening as the lesser palatine foramen at its inferior aspect. The lesser and greater palatine canals house the lesser and greater palatine nerves, respectively; these serve as efferent branches from the PPG to the palate. Upon scrolling up, the PPF appears as a small oval space bounded anteriorly by the posterior wall of the maxillary sinus, medially by the palatine bone and posteriorly by the pterygoid plates (Fig. 2b). Laterally, the PPF communicates with the infratemporal fossa (ITF) via the pterygomaxillary fissure (PMF) (Fig. 2c and d). The roof of the PPF is formed by the sphenoid bone. The PPF communicates with the foramen lacerum via the Vidian canal (Fig. 2c), which traverses posterolaterally through the body of the sphenoid bone. The Vidian canal contains the Vidian nerve, which carries parasympathatic preganglionic fibres from the facial nerve to the PPG. The postganglionic fibres from the PPG supply the lacrimal gland and the mucosa of the nasal cavity and nasopharynx. At about the same level, the PPF also communicates with the nasal cavity via the sphenopalatine foramen (SPF) (Fig. 2c and d), just anterior to the Vidian canal opening. At its most cranial aspect (base of pyramid), the PPF communicates with the orbit via the inferior orbital fissure (IOF) (Fig. 2d and f). The IOF transmits the zygomatic branch of V2, ascending branches from the PPG and the ION. At the same level, the foramen rotundum (Fig. 2e and f) also enters the posterosuperior aspect of the PPF, communicating with the middle cranial fossa. The V2 nerve travels through the foramen rotundum to enter the PPF and continues further as the ION [1–4].
While CT is useful for studying bony anatomy, magnetic resonance imaging (MRI) is excellent for evaluating pathologies of the PPF, especially perineural tumour spread (PNS). High-resolution, thin-section (2–3 mm), small field-of-view MRI using a head-coil is recommended for evaluating the PPF and its connections. Precontrast axial SE T1W, axial FSE T2W and coronal SE T1W images followed by gadolinium-enhanced, fat-saturated (FS) axial and coronal SE T1W images are routinely acquired [5–7]. 3D FT T1W sequences with 0.6–1-mm-thin slices (VIBE-Volumetric Interpolated Examination) after intravenous contrast administration are additionally used by some investigators including ourselves. These volumetric data sets allow multiplanar reconstructions in any given plane and thereby facilitate the evaluation of subtle abnormalities [8].
Key CT and MR imaging appearances in PPF pathology
On non-contrast enhanced CT (NECT) with soft-tissue window settings, the normal PPF appears as a hypodense, fat-density space (Fig. 3a). On T1W MR images, normal fat within the PPF shows hyperintense signal (Fig. 3b and c). It may contain small flow voids from branches of the internal maxillary artery. The PPF is not seen on imaging. Mild post-contrast MR enhancement within the PPF is normal, due to the presence of small emissary veins [1, 5, 7].
Obliteration or replacement of the fat with soft tissue, widening of the PPF, and bony erosion of its walls are key imaging findings of its pathological involvement. Enlargement of communicating neural foramina and/or infiltration of the fat within the neural foramina suggests PNS. Osseous abnormalities are best seen on CT whilst replacement of fat is best seen on T1W MR images. Contrast-enhanced T1W MR images, especially with fat-saturation, can elegantly demonstrate PNS within the PPF [5–8].
PPF pathology
Various neoplastic as well as infective and inflammatory conditions are known to involve the PPF. These pathologies can extend to the PPF either by direct spread or via the neurovascular communications. The presence of disease like PNS within the PPF has serious treatment and prognostic implications—it often portends recurrence, need for wider surgical resection, expansion of radiotherapy (RT) portals, and at times, poor prognosis [5–7, 9].
Neoplastic conditions
The PPF can be involved either by direct tumour invasion or by PNS. Direct invasion of the PPF is often seen in tumours of the nasal cavity/nasopharynx like juvenile nasopharyngeal angiofibroma (JNA), nasopharyngeal carcinoma (NPC), and in masticator space sarcomas. PNS is a well-known form of spread in head-neck cancers in which there is gross, radiologically evident disease spread along large nerves. It commonly occurs in a retrograde fashion, toward the central nervous system. Since the PPF is a central station in the trigeminal nerve pathway, it is often the site of PNS, typically from cancers of the palate, cheek, maxillary sinus, and nasopharynx [5–7, 9–11]. Imaging is critical for diagnosing PNS as it may be clinically silent in about 40 % of patients [6].
Direct tumour invasion into the PPF
JNA
JNA is a benign, vascular, locally aggressive tumour, which originates in the SPF. Its direct lateral extension into the PPF is considered the most important event in its expansion, as it can then have multidirectional invasion into the maxillary sinus anteriorly, the ITF laterally via the PMF (Fig. 4), the pterygoid fossa posteriorly, and the orbit/cranial fossa superiorly via the IOF. Besides the IOF, JNA can extend from the PPF further intracranially via the Vidian canal. Locally, it produces widening of the PPF with bowing and erosions of its bony walls. The multidirectional extension of JNA from the PPF is associated with higher morbidity due to the involvement of more important structures as opposed to its multidirectional extension from its origin in the SPF [10–13].
Over the years, various staging systems based on tumour extension have been utilized for stratifying patients with JNA. These systems identify lesions amenable to resection by either endoscopic, external, or combined approach, and also the extent of resection. Commonly used staging systems are from Sessions et al., Andrews et al., Radkowski et al., Onerci et al., and Carrillo et al. In most of these, involvement of the PPF is classified as stage II, whereas involvement of ITF or intracranial extension is classified as stage III or IV. Currently, endoscopic excision of JNA extending up to the PPF is considered as standard treatment with high rates of complete resection and minimal morbidity. However, lesions extending into the ITF or intracranially require external approaches, which are technically more challenging. Additional craniotomy and RT may be required for extensive disease [10–13].
NPC
NPC is an aggressive primary mucosal malignancy arising in the nasopharynx. It can directly spread anteriorly into the nasal cavity (AJCC, American Joint Committee on Cancer, 7th edition–stage T1) from which it can extend further into the PPF through the SPF (Fig. 5a and b). About 15 % of patients show involvement of the PPF at the time of diagnosis (AJCC stage T3) [14, 15]. From the PPF, the tumour commonly extends via the IOF into the orbit and via the PMF into the masticator space, both of which are categorized as AJCC stage T4 (Fig. 5c). PNS in NPC commonly occurs in a retrograde fashion, from the PPF to the middle cranial fossa along the V2 nerve, which is also considered stage T4 disease (Fig. 5d) [14–17].
Orbital invasion is seen in about 15 % of cases at the time of diagnosis. It is associated with sinister prognosis, with a 5-year survival rate of about 30 % [16–19].
The frequency of masticator space involvement is about 19.7 %. Its involvement is an independent prognostic factor for overall survival and local relapse-free survival of patients with NPC. These patients may require combined chemotherapy and RT as compared to RT alone in earlier stages of the disease. Also, higher doses of RT may be required [20].
Since RT remains the cornerstone of treatment in NPC, the identification of PNS is of paramount importance, as recurrence is guaranteed if it is missed in the RT field. Also, PNS and cranial nerve involvement are associated with poorer survival and poorer distant-metastases-free survival [9, 21].
Masticator space sarcomas
Mesenchymal tumours such as rhabdomyosarcoma (RMS), fibrosarcoma, etc. are common primary tumours of the masticator space/ITF. Sarcomas of the masticator space can directly extend medially via the PMF and infiltrate the PPF, which then acts as a highway for further intracranial spread of disease (Fig. 6) [22–25].
RMS of the PPF/ITF carries a poorer prognosis as compared to RMS arising in the nasal cavity, nasopharynx, and parapharyngeal region. In terms of management, tumours arising in PPF/ITF are usually considered unresectable and are treated with a combination of high-dose RT and chemotherapy. Despite the use of large fields and high-dose RT, local control remains a challenge and is the most frequent type of disease progression. Moreover, large RT fields and doses are associated with serious sequels like the impact on growth of facial bones in young children. Some authors suggest extensive surgery in combination with RT for improving local control in these tumours [26].
PNS to the PPF
Cancers of the palate
The palate has a high concentration of minor salivary glands and hence, tumours of minor salivary gland origin are very prevalent in the palate. Of these, the vast majority are adenoid cystic carcinomas (ACC). ACCs show a high propensity for PNS (almost 60 % cases). Squamous cell carcinomas (SCC), which arise in the hard palate, are also known to cause PNS [27]. The bulk of the neural supply to the palate is by the lesser and greater palatine nerves and hence, PNS from carcinomas of the palate commonly occurs in retrograde to the PPF via these two nerves. From the PPF, PNS further extends along V2 and the Vidian nerve into the middle cranial fossa and the cavernous sinuses (Fig. 7a, b, c and d). According to the 7th edition of UICC/International Union Against Cancer 2009, involvement of the PPF is not included in the T-staging of oropharyngeal (soft palate) or oral cavity (hard palate) cancers. Save for PNS along the ION in maxillary sinus tumours, PNS always indicates the highest T-stage in head and neck cancers according to the UICC staging system. It is considered an independent prognostic factor with a nearly three-fold increase in local recurrence and approximately 30 % decrease in 5-year survival rate [28, 29]. It portends the need for concurrent chemoradiotherapy, as opposed to surgical resection for smaller lesions (T1 or T2) restricted to the palate [30].
Cancers of the maxillary sinus
The maxillary sinus is most commonly affected by SCC and occasionally by ACC, both of which are known for PNS. The PPF may be directly involved by tumour spread through the posterior wall of the sinus or it may be involved by PNS via the posterior superior alveolar nerve(s) and/or ION (both being branches of V2) via the IOF [6, 10, 29, 31, 32]. Involvement of the PPF indicates stage 3 as per the UICC [28].
The presence of PNS is associated with increased risk of tumour recurrence, necessitating more aggressive treatment. Increased morbidity is a result of more extensive surgical resection, addition of adjuvant RT and/or widening of RT field [31, 32].
Cancers of the cheek
Cutaneous malignancies of the cheek like SCC and basal cell carcinoma can also extend perineurally to the PPF via branches of the ION. PNS occurs in approximately 2.5–5 % of primary cutaneous SCCs [33]. Accurate assessment of the presence and extent of PNS plays a pivotal role in the staging, management, and prognosis of patients with cutaneous SCC. In accordance with the AJCC, 7th edition, the presence of perineural invasion is considered a high-risk characteristic of T1 and T2 lesions, whilst the presence of perineural involvement of the skull base is categorized as T4. The involvement of larger calibre nerves (which are visible on imaging) is associated with an elevated risk of nodal metastasis and death. Along with the other risk factors (such as depth of invasion or degree of differentiation), PNS may require adjuvant RT along with surgical excision [33, 34].
Infective and inflammatory conditions
The PPF can be involved by the spread of invasive fungal sinusitis, bacterial sinusitis, and less often, in inflammatory conditions like inflammatory pseudotumour (IPT) [35–41].
Invasive fungal sinusitis
It commonly occurs in patients with immunocompromised states or uncontrolled diabetes (Fig. 8a, b and c). It is a progressive and often life-threatening disease, which often extends beyond the paranasal sinuses into the PPF, ITF, and intracranial cavity. Invasion of the PPF may occur either via direct erosion of the sinus walls of by perivascular infiltration. From the PPF, the disease shows easy access to the middle cranial fossa and cavernous sinus, leading to serious complications like cavernous sinus thrombosis, arterial mycotic aneurysms, infarcts, and abscesses. Extension into the PPF and ITF require rapid surgical debridement (which can be often very challenging in this area) in addition to aggressive antifungal therapy [35–38].
Bacterial sinusitis
Abscess formation in the PPF has been described secondary to dental/periodontal disease. Although rare, perineural spread of infection to the PPF can also be seen in bacterial sinusitis caused by E.coli, P. aeruginosa, or by streptococci. It should be suspected whenever patients with sinusitis present with symptoms related to any of the V2 branches (Fig. 9a, b and c) [39, 40].
IPT
IPT is a rare, biologically controversial entity in the head and neck that represents an idiopathic, non-granulomatous inflammation with myofibroblastic proliferation. IPT often behaves quite aggressively, resulting in wide-spread soft tissue involvement and bony destruction, which can make differentiation from a malignant lesion challenging. In the suprahyoid neck, IPT may affect the orbital contents, the paranasal sinuses and the masticator space. IPT is not associated with infection, neoplasm, or systemic disease; it has protean clinical manifestations depending on the type and location of the inflammation. Although IPTs most often arise in the orbit, extra-orbital extension may occasionally occur via the superior orbital fissure or IOF or via the optic canal. Involvement of the PPF (via the IOF). (Fig. 10a, b and c) is usually a mark of extensive disease and reflects a chronic process (present insidiously over months), which has been reported to have less favorable therapeutic outcomes as compared to the acute form [41–44].
Potential pitfalls in imaging of the PPF
Infective and inflammatory conditions in the PPF may mimic the perineural spread of malignancy. A schwannoma may also mimic PNS by causing thickening and enhancement of the affected nerve. Clinical correlation is essential to look for sinusitis/mucormycosis, etc. Image-guided fine-needle aspiration of abnormal soft tissue may provide further evaluation in selected cases [6, 29]. The PPF is commonly disrupted during surgical extirpation of large or posteriorly situated maxillary sinus tumours. After surgical violation, the PPF almost always appears abnormal on MRI with persistent abnormal soft tissue and often enhancement within. These expected imaging findings of scar tissue may be misdiagnosed as residual or recurrent disease. Obtaining an early post-operative baseline scan, and serial imaging for stability of findings, absence of new local mass lesion, and absence of new PNS are useful radiological tools in this scenario [7].
Conclusion
The PPF is a ‘central station’ in the deep face where various neurovascular crossroads meet; it acts as a relay terminus for the spread of tumour, infection, and inflammation from one deep neck space to another. Hence, in pathologies of the adjacent spaces, it is necessary to review all the anatomical connections of the PPF to avoid missing out on subtle disease lurking in a blind spot. This pictorial essay serves to concisely review the anatomy of the PPF and to highlight diagnostic pearls and potential pitfalls while imaging PPF pathology.
Acknowledgments
Figures 5a, b and c and 10a, b and c were previously displayed at RSNA 2013. (Purohit BS et al. The pterygopalatine fossa: Imaging anatomy, communications and pathology RSNA 2013 EPOS-archive.rsna.org/2013/13021664.html). The authors declare no conflicts of interest. Figure 5d was previously displayed at ESHNR 2013 (EP-02 Perineural tumour spread in head and neck cancers: A case based pictorial review B.S. Purohit, al. EPOS ESHNR 2013).
Abbreviations
- PPF
Pterygopalatine fossa
- PNS
Perineural tumour spread
- PPG
Pterygopalatine ganglion
- ITF
Infratemporal fossa
- PMF
Pterygomaxillary fissure
- IOF
Inferior orbital fissure
- ION
Infraorbital nerve
- SPF
Sphenopalatine foramen
- NPC
Nasopharyngeal carcinoma
- SCC
Squamous cell carcinoma
- ACC
Adenoid cystic carcinoma
- RMS
Rhabdomyosarcoma
- IPT
Inflammatory pseudotumour
- HRCT
High-resolution CT
- NECT
Non-contrast-enhanced CT
- CECT
Contrast-enhanced CT
- CEMRI
Contrast-enhanced MR
- FS
Fat-saturated
- RT
Radiotherapy
- AJCC TNM
American Joint Committee on Cancer (tumour, node, metastasis) classification
- UICC
International Union Against Cancer
Footnotes
Dr. Sonam Tashi and Dr. Bela Purohit are joint first authors.
References
- 1.Curtin HD, Williams R. Computed tomographic anatomy of the pterygopalatine fossa. Radiographics. 1985;5:429–440. doi: 10.1148/radiographics.5.3.429. [DOI] [Google Scholar]
- 2.Daniels DL, Mark LP, Ulmer JL, Mafee MF, McDaniel J, Shah NC, et al. Osseous anatomy of the pterygopalatine fossa. AJNR Am J Neuroradiol. 1998;19:1423–1432. [PMC free article] [PubMed] [Google Scholar]
- 3.Kim HS, Kim DI, Chung IH. High-resolution CT of the pterygopalatine fossa and its communications. Neuroradiology. 1996;38:S120–126. doi: 10.1007/BF02278138. [DOI] [PubMed] [Google Scholar]
- 4.Erdogan N, Erdogan U, Baykara M. CT anatomy of pterygopalatine fossa and its communications: a pictorial review. Comput Med Imaging Graph. 2003;27:481–487. doi: 10.1016/S0895-6111(03)00038-7. [DOI] [PubMed] [Google Scholar]
- 5.Tomura N, Hirano H, Kato K, Takahashi S, Sashi R, Tate E, et al. Comparison of MR imaging with CT in depiction of tumour extension into the pterygopalatine fossa. Clin Radiol. 1999;54:361–366. doi: 10.1053/crad.1999.0179. [DOI] [PubMed] [Google Scholar]
- 6.Moonis G, Cunane MB, Emerick K, Curtin H. Patterns of perineural tumor spread in head and neck cancer. Magn Reson Imaging Clin N Am. 2012;20:435–446. doi: 10.1016/j.mric.2012.05.006. [DOI] [PubMed] [Google Scholar]
- 7.Chan LL, Chong J, Gillenwater AM, Ginsberg LE. The pterygopalatine fossa: postoperative MR imaging appearance. Am J Neuroradiol. 2000;2:1315–1319. [PMC free article] [PubMed] [Google Scholar]
- 8.Kirsch CFE. Advantages in magnetic resonance imaging of the skull base. Int Arch Otorhinolaryngol. 2014;18:S127–S135. doi: 10.1055/s-0034-1390013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Yousem DM, Gad K, Tufano RP. Resectability issues with head and neck cancer. AJNR Am J Neuroradiol. 2006;27:2024–2036. [PMC free article] [PubMed] [Google Scholar]
- 10.Maroldi R, Nicolai P, editors. Imaging in treatment planning for sinonasal diseases. New York: Springer Verlag; 2004. pp. 107–158. [Google Scholar]
- 11.Sennes LU, Butugan O, Sanchez TG, Bento RF, Tsuji DH. Juvenile nasopharyngeal angiofibroma: the routes of invasion. Rhinology. 2003;41:235–240. [PubMed] [Google Scholar]
- 12.Eloy P, Watelet JB, Hatert AS, de Wispelaere J, Bertrand B. Endonasal endoscopic resection of juvenile nasopharyngeal angiofibroma. Rhinology. 2007;45:24–30. [PubMed] [Google Scholar]
- 13.Nicolai P, Schreiber A, Villaret AB. Juvenile angiofibroma: evolution of management. Int J Pediatr. 2012;2012:412545. doi: 10.1155/2012/412545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chong VF, Fan YF. Pterygopalatine fossa and maxillary nerve infiltration in nasopharyngeal carcinoma. Head Neck. 1997;19:121–125. doi: 10.1002/(SICI)1097-0347(199703)19:2<121::AID-HED6>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
- 15.Chong VF, Fan YF, Khoo JB, Lim TA. Comparing computed tomographic and magnetic resonance imaging visualisation of the pterygopalatine fossa in nasopharyngeal carcinoma. Ann Acad Med Singapore. 1995;24:436–441. [PubMed] [Google Scholar]
- 16.Luo CB, Teng MM, Chen SS, Lirng JF, Guo WY, Chang T. Orbital invasion in nasopharyngeal carcinoma: evaluation with computed tomography and magnetic resonance imaging. Zhonghua Yi Xue Za Zhi. 1998;61:382–388. [PubMed] [Google Scholar]
- 17.Razek AAKA, King A. MRI and CT of nasopharyngeal carcinoma. AJR Am J Roentgenol. 2012;198:11–8. doi: 10.2214/AJR.11.6954. [DOI] [PubMed] [Google Scholar]
- 18.Heng DMK, Wee J, Fong KW, Lian LG, Sethi VK, Chua ET, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 1999;15:1912–1920. doi: 10.1002/(SICI)1097-0142(19991115)86:10<1912::AID-CNCR6>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
- 19.Au JSK, Law CK, Foo W, Lau WH. In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: prognostic homogeneity and proposed refinement. Int J Radiat Oncol Biol Phys. 2003;56:413–426. doi: 10.1016/S0360-3016(02)04610-2. [DOI] [PubMed] [Google Scholar]
- 20.Tang LL, Li WF, Chen L, Sun Y, Chen Y, Liu LZ, et al. Prognostic value and staging categories of anatomic masticator space involvement in nasopharyngeal carcinoma: a study of 924 cases with MR imaging. Radiology. 2010;257:151–157. doi: 10.1148/radiol.10100033. [DOI] [PubMed] [Google Scholar]
- 21.Liu L, Liang S, Li L, Mao Y, Tang L, Tian L, et al. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma. Cancer. 2009;115:1995–2003. doi: 10.1002/cncr.24201. [DOI] [PubMed] [Google Scholar]
- 22.Tiwari R, Quak J, Egeler S, Smeele L, Waal IV, Valk PV, et al. Tumors of the infratemporal fossa. Skull Base Surg. 2000;10:1–9. doi: 10.1055/s-2000-6789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Freling NJM, Merks JHM, Saeed P, Balm AJM, Bras J, Pieters BR, et al. Imaging findings in craniofacial childhood Rhabdomyosarcoma. Pediatr Radiol. 2010;40:1723–1738. doi: 10.1007/s00247-010-1787-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yu Q, Wang P, Shi H, Luo J, Sun D. The lesions of the pterygopalatine and infratemporal spaces: computed tomography evaluation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:742–51. doi: 10.1016/S1079-2104(98)90045-2. [DOI] [PubMed] [Google Scholar]
- 25.Becker M, Kohler R, Vargas MI, Viallon M, Delavelle J. Pathology of the trigeminal nerve. Neuroimaging Clin N Am. 2008;18:283–307. doi: 10.1016/j.nic.2007.11.002. [DOI] [PubMed] [Google Scholar]
- 26.Minard-Colin V, Kolb F, Saint-Rose C, Fayard F, Janot F, Rey A, et al. Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcoma. Pediatr Blood Cancer. 2013;60:928–934. doi: 10.1002/pbc.24374. [DOI] [PubMed] [Google Scholar]
- 27.Ginsberg LE, DeMonte F. Imaging of perineural tumor spread from palatal carcinoma. AJNR Am J Neuroradiol. 1998;19:1417–1422. [PMC free article] [PubMed] [Google Scholar]
- 28.Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7. Washington, DC: Wiley-Blackwell; 2009. [Google Scholar]
- 29.Ong CK, Chong VFH. Imaging of perineural spread in head and neck tumours. Cancer Imaging. 2010;10:S92–S98. doi: 10.1102/1470-7330.2010.9033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Trotta BM, Pease CS, Rasamny JJ, Raghavan P, Mukherjee S. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics. 2011;31:339–54. doi: 10.1148/rg.312105107. [DOI] [PubMed] [Google Scholar]
- 31.Gil Z, Carlson DL, Gupta A, Lee N, Hoppe B, Shah JP, et al. Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2009;135:173–179. doi: 10.1001/archoto.2008.525. [DOI] [PubMed] [Google Scholar]
- 32.Kazi M, Awan S, Junaid M, Qadeer S, Hassan NH. Management of sinonasal tumors: prognostic factors and outcomes: a 10 years experience at a tertiary care hospital. Indian J Otolaryngol Head Neck Surg. 2013;65:155–159. doi: 10.1007/s12070-013-0650-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion. JAMA Dermatol. 2013;149:35–41. doi: 10.1001/jamadermatol.2013.746. [DOI] [PubMed] [Google Scholar]
- 34.Gurudutt VV, Genden EM. Cutaneous squamous cell carcinoma of the head and neck. J Skin Cancer. 2011;2011:502723. doi: 10.1155/2011/502723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Goyal P, Leung MK, Hwang PH. Endoscopic approach to the infratemporal fossa for treatment of invasive fungal sinusitis. Am J Rhinol Allergy. 2009;23:100–104. doi: 10.2500/ajra.2009.23.3270. [DOI] [PubMed] [Google Scholar]
- 36.Kim TH, Jang HU, Jung YY, Kim JS. Granulomatous invasive fungal rhinosinusitis extending into the pterygopalatine fossa and orbital floor. Med Mycol Case Rep. 2012;1:107–111. doi: 10.1016/j.mmcr.2012.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262:932–938. doi: 10.1007/s00405-005-0919-0. [DOI] [PubMed] [Google Scholar]
- 38.Maschio M, Mengarelli A, Girmenia C, Vidire A, Kayal R, Gallo MT, et al. Trigeminal neuralgia as unusual isolated symptom of fungal paranasal sinusitis in patients with haematological malignancies. Neurol Sci. 2012;33:647–652. doi: 10.1007/s10072-011-0808-9. [DOI] [PubMed] [Google Scholar]
- 39.Hostler HB, Okumoto M. Infections of the eye and orbit. In: Schlossberg D, editor. Infections of the head and neck. Berlin: Springer Verlag; 2012. pp. 14–42. [Google Scholar]
- 40.Lale AM, Jani PJ, Ellis PD. An unusual complication of chemotherapy: an abscess in the pterygopalatine fossa. J Laryngol Otol. 1998;112:296–297. doi: 10.1017/s0022215100158402. [DOI] [PubMed] [Google Scholar]
- 41.Park SB, Lee JH, Weon YC. Imaging findings of head and neck inflammatory pseudotumor. AJR Am J Roentgenol. 2009;193:1180–1186. doi: 10.2214/AJR.09.2398. [DOI] [PubMed] [Google Scholar]
- 42.Becker M, Masterson K, Delavelle J, Viallon M, Vargas MI, Becker CD. Imaging of the optic nerve. Eur J Radiol. 2010;74(2):299–313. doi: 10.1016/j.ejrad.2009.09.029. [DOI] [PubMed] [Google Scholar]
- 43.Lee EJ, Jung SL, Kim BS, Ahn KJ, Kim YJ, Jung AK, et al. MR imaging of orbital inflammatory pseudotumors with extraorbital extension. Korean J Radiol. 2005;6:82–88. doi: 10.3348/kjr.2005.6.2.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121:491–499. doi: 10.1001/archopht.121.4.491. [DOI] [PubMed] [Google Scholar]